.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Farmers Insurance
McKesson
US Department of Justice
Harvard Business School
Johnson and Johnson
Citi
Daiichi Sankyo
Healthtrust
Deloitte

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,314,447

« Back to Dashboard

Which drugs does patent 9,314,447 protect, and when does it expire?


Patent 9,314,447 protects ANTARA (MICRONIZED) and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 9,314,447

Title:Reduced dose pharmaceutical compositions of fenofibrate
Abstract: The present invention provides a reduced dose oral pharmaceutical composition comprising mixture of nanoparticulate fenofibrate and micronized fenofibrate and one or more pharmaceutically acceptable excipients.
Inventor(s): Kallem; Venkat Reddy (Hyderabad, IN), Kasu; Raghu Rami Reddy (Maharashtra, IN), Das; Subhasis (Maharashtra, IN), Thommandru; Vijaya Kumar (Maharashtra, IN)
Assignee: Lupin Atlantis Holdings, S.A. (Schaffhausen, CH)
Application Number:13/854,389
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Lupin Atlantis
ANTARA (MICRONIZED)
fenofibrate
CAPSULE;ORAL021695-005Oct 18, 2013RXYesNo9,314,447► SubscribeY TREATING PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA
Lupin Atlantis
ANTARA (MICRONIZED)
fenofibrate
CAPSULE;ORAL021695-005Oct 18, 2013RXYesNo9,314,447► SubscribeY TREATING SEVERE HYPERTRIGLYCERIDEMIA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 9,314,447

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India1397/KOL/2012Dec 11, 2012

International Patent Family for Patent: 9,314,447

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Switzerland707330► Subscribe
World Intellectual Property Organization (WIPO)2014091318► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Argus Health
Boehringer Ingelheim
Farmers Insurance
Fuji
Medtronic
Deloitte
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot